From an immune perspective, the observed increase in expression of semaphorin (SEMA), S100A proteins, and cytokines (CXCL) suggests the activation of an inflammatory response (48–50), which is a well-described consequence of radiotherapy within the tumour microenvironment (57, 58). This evidence concerns the gene S100A1 and neoplasm.